These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17875748)

  • 21. Imatinib resistance in CML.
    Volpe G; Panuzzo C; Ulisciani S; Cilloni D
    Cancer Lett; 2009 Feb; 274(1):1-9. PubMed ID: 18653275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Strategy for patients with GIST after failure of imatinib].
    Abe S; Kubota T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):540-3. PubMed ID: 19381023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer drug effective in RA.
    Duke Med Health News; 2006 Dec; 12(12):2. PubMed ID: 17294533
    [No Abstract]   [Full Text] [Related]  

  • 24. Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors.
    Nilsson B; Andersson A; Ahlman H
    J Surg Oncol; 2008 Sep; 98(3):145-6. PubMed ID: 18452216
    [No Abstract]   [Full Text] [Related]  

  • 25. [Limitations in application of imatinib in hematologic malignancies: are there new principal solutions?].
    Rukavitsyn OA; Pop VP
    Ter Arkh; 2008; 80(7):80-4. PubMed ID: 18763606
    [No Abstract]   [Full Text] [Related]  

  • 26. [A step foward in the treatment of GIST].
    Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(4):223-4. PubMed ID: 18776977
    [No Abstract]   [Full Text] [Related]  

  • 27. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
    Chien JH; Tang JL; Chen RL; Li CC; Lee CP
    Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Locally advanced GISTs need aggressive therapy pending the results of trials.
    Date RS; Mughal MM
    Ann Surg Oncol; 2008 May; 15(5):1540-1; author reply 1542-3. PubMed ID: 18058180
    [No Abstract]   [Full Text] [Related]  

  • 30. Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy.
    Jilani I; Kantarjian H; Gorre M; Cortes J; Ottmann O; Bhalla K; Giles FJ; Albitar M
    Leuk Res; 2008 Apr; 32(4):643-9. PubMed ID: 17900686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.
    Dvorak P; Hruba M; Subrt I
    Leuk Res; 2009 Jun; 33(6):860-1. PubMed ID: 18977531
    [No Abstract]   [Full Text] [Related]  

  • 32. Mathematical models of cancer stem cells.
    Michor F
    J Clin Oncol; 2008 Jun; 26(17):2854-61. PubMed ID: 18539964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor stabilization under treatment with imatinib in progressive hypothalamic-chiasmatic glioma.
    Peyrl A; Azizi A; Czech T; Gruber-Olipitz M; Jones N; Haberler C; Prayer D; Autzinger E; Slavc I
    Pediatr Blood Cancer; 2009 Apr; 52(4):476-80. PubMed ID: 19061223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML.
    Rokicka M; Styczynski J; Michalewska B; Torosian T; Tomaszewska A; Gronkowska A; Pogorzala M; Wysocki M; Lakomy M; Wiktor-Jedrzejczak W
    Bone Marrow Transplant; 2009 Sep; 44(6):383-5. PubMed ID: 19219078
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary resistance to imatinib in Fip1-like 1-platelet-derived growth factor receptor alpha-positive eosinophilic leukemia.
    Simon D; Salemi S; Yousefi S; Simon HU
    J Allergy Clin Immunol; 2008 Apr; 121(4):1054-6. PubMed ID: 18234315
    [No Abstract]   [Full Text] [Related]  

  • 36. Should adjuvant imatinib be used as primary treatment for gastrointestinal stromal tumors?
    Hohenberger P
    Nat Clin Pract Oncol; 2008 May; 5(5):240-1. PubMed ID: 18349856
    [No Abstract]   [Full Text] [Related]  

  • 37. PDGFR inhibition in brain tumours--oft expectation fails where most it promises.
    Raymond E
    Eur J Cancer; 2009 Sep; 45(13):2236-8. PubMed ID: 19540747
    [No Abstract]   [Full Text] [Related]  

  • 38. Where lies the blame for resistance--tumor or host?
    Sawyers CL
    Nat Med; 2007 Oct; 13(10):1144-5. PubMed ID: 17917659
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of gene profiling in chronic myeloid leukaemia.
    Yong AS; Melo JV
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):181-90. PubMed ID: 19698927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dodging a dogma: is treating beyond progression beneficial?
    Naing A; Kurzrock R
    Cancer Chemother Pharmacol; 2013 May; 71(5):1385-6. PubMed ID: 23443308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.